New Classifications of Five Distinct “Sleep” Profi... ...
Science in the Age of AI | AI for Science Forum...
Ask the Heart Doctor | Heart Valve Disease and Sur...
High-speed imaging tracks live brain cell activity...
NAD⁺ restores memory in Alzheimer's disease models...
Mark Cuban: A Master Disrupter for American Health...
Teen girls facing the most adversity showed the biggest gain...
September 15,2026
Specialized imaging reveals hormone-driven brain changes...
September 14,2026
Submillimeter MRI reveals brain hubs that guide risky decisi...
September 12,2026
Risk of herpes zoster among breast cancer survivors in Japan...
September 11,2026
Three proteins help organs tailor shared circadian clock to ...
September 10,2026
Should you worry about melatonin and heart failure? The evid...
December 02,2025
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
GOSH BRC Showcase 2025 - Genomic medicine...
Can a twice-a-year shot help end the HIV...
Announcement of the 2025 Nobel Prize in ...
Reprogramming Stem Cells Could Cure Type...
Why MDMA did NOT get FDA approval...
More News
Q&A: DoxyPEP, a 'morning-after pill' for STIs

Q&A: DoxyPEP, a 'morning-after pill' for STIs

by Stephanie Desmon,Johns Hopkins University Bloomberg School of Public HealthCredit: Pixabay/CC0 Public DomainThere has been an alarming increase in sexually transmitted infections in the U.S.
Q & A January 26,2024
Q&A: DoxyPEP, a 'morning-after pill' for STIs

Q&A: DoxyPEP, a 'morning-after pill' for STIs

by Stephanie Desmon,Johns Hopkins University Bloomberg School of Public HealthCredit: Pixabay/CC0 Public DomainThere has been an alarming increase in sexually transmitted infections in the U.S.
Q & A January 26,2024
Researchers translate a hypothesis into a personalized treatment for cancer

Researchers translate a hypothesis into a personalized treatment for cancer

byUniversity of CalgaryFranz Zemp designed a personalized CAR T-cell therapy for a Calgary teen. Credit: Arnie Charbonneau Cancer Institute, University of CalgaryDr. Franz Zemp, Ph.D., gets chil
Oncology January 26,2024
Researchers translate a hypothesis into a personalized treatment for cancer

Researchers translate a hypothesis into a personalized treatment for cancer

byUniversity of CalgaryFranz Zemp designed a personalized CAR T-cell therapy for a Calgary teen. Credit: Arnie Charbonneau Cancer Institute, University of CalgaryDr. Franz Zemp, Ph.D., gets chil
Oncology January 26,2024
Researchers redesign future mRNA therapeutics to prevent potentially harmful immune responses

Researchers redesign future mRNA therapeutics to prevent potentially harmful immune responses

byUniversity of CambridgeBiochemist Professor Anne Willis and immunologist Dr James Thaventhiran at the MRC Toxicology Unit at the University of Cambridge led this work. Credit: Mike Thornton, S
Immunology & Rheumatology January 26,2024
Researchers redesign future mRNA therapeutics to prevent potentially harmful immune responses

Researchers redesign future mRNA therapeutics to prevent potentially harmful immune responses

byUniversity of CambridgeBiochemist Professor Anne Willis and immunologist Dr James Thaventhiran at the MRC Toxicology Unit at the University of Cambridge led this work. Credit: Mike Thornton, S
Immunology & Rheumatology January 26,2024
Why you might not find your favorite cold meds at the pharmacy

Why you might not find your favorite cold meds at the pharmacy

by Levi Gadye,University of California, San FranciscoCredit: CC0 Public DomainIt's winter and many people are contending with the sniffles and coughs. For some, that means heading to the pha
Breakthroughs January 26,2024
Why you might not find your favorite cold meds at the pharmacy

Why you might not find your favorite cold meds at the pharmacy

by Levi Gadye,University of California, San FranciscoCredit: CC0 Public DomainIt's winter and many people are contending with the sniffles and coughs. For some, that means heading to the pha
Breakthroughs January 26,2024
Protective antibody targets conserved site of fusion glycoprotein of respiratory syncytial virus

Protective antibody targets conserved site of fusion glycoprotein of respiratory syncytial virus

by Tsinghua University PressHuman neutralizing antibodies against RSV are isolated from the convalescent children. One potent monoclonal antibody RV11 potently neutralizes and prevent RSV infection, w
Public Health & Prevention January 26,2024
Protective antibody targets conserved site of fusion glycoprotein of respiratory syncytial virus

Protective antibody targets conserved site of fusion glycoprotein of respiratory syncytial virus

by Tsinghua University PressHuman neutralizing antibodies against RSV are isolated from the convalescent children. One potent monoclonal antibody RV11 potently neutralizes and prevent RSV infection, w
Public Health & Prevention January 26,2024
Ozempic overdose? Poison control experts explain why thousands OD'd in 2023

Ozempic overdose? Poison control experts explain why thousands OD'd in 2023

by Jeremy Childs, Los Angeles TimesCredit: Unsplash/CC0 Public DomainSome of those taking Ozempic or Wegovy are learning that too much of a good thing is never good.Semaglutide, the medication prescri
Breakthroughs January 26,2024
Ozempic overdose? Poison control experts explain why thousands OD'd in 2023

Ozempic overdose? Poison control experts explain why thousands OD'd in 2023

by Jeremy Childs, Los Angeles TimesCredit: Unsplash/CC0 Public DomainSome of those taking Ozempic or Wegovy are learning that too much of a good thing is never good.Semaglutide, the medication prescri
Breakthroughs January 26,2024
Mantle cell lymphoma patients see improved outcomes with oral combination of ibrutinib and venetoclax

Mantle cell lymphoma patients see improved outcomes with oral combination of ibrutinib and venetoclax

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainThe targeted therapy combination of ibrutinib and venetoclax significantly improved progression-free survival (
Breakthroughs January 26,2024
Mantle cell lymphoma patients see improved outcomes with oral combination of ibrutinib and venetoclax

Mantle cell lymphoma patients see improved outcomes with oral combination of ibrutinib and venetoclax

byUniversity of Texas M. D. Anderson Cancer CenterCredit: Pixabay/CC0 Public DomainThe targeted therapy combination of ibrutinib and venetoclax significantly improved progression-free survival (
Breakthroughs January 26,2024
For metastatic prostate cancer, immunotherapy may have unexpected potential

For metastatic prostate cancer, immunotherapy may have unexpected potential

byColumbia University Irving Medical CenterCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.10.006Immunotherapy has been disappointing as a prostate cancer treatment, but a new Co
Oncology January 26,2024
For metastatic prostate cancer, immunotherapy may have unexpected potential

For metastatic prostate cancer, immunotherapy may have unexpected potential

byColumbia University Irving Medical CenterCredit:Cancer Cell(2023). DOI: 10.1016/j.ccell.2023.10.006Immunotherapy has been disappointing as a prostate cancer treatment, but a new Co
Oncology January 26,2024
Q&A: What to know about weight loss drugs

Q&A: What to know about weight loss drugs

byTufts UniversityCredit: Unsplash/CC0 Public DomainThe biggest health and nutrition story of 2023 was arguably the exploding popularity of prescription medications to treat obesity, a chronic d
Q & A January 26,2024
Q&A: What to know about weight loss drugs

Q&A: What to know about weight loss drugs

byTufts UniversityCredit: Unsplash/CC0 Public DomainThe biggest health and nutrition story of 2023 was arguably the exploding popularity of prescription medications to treat obesity, a chronic d
Q & A January 26,2024
Biomedical engineers unveil the dynamics of maternal immune responses

Biomedical engineers unveil the dynamics of maternal immune responses

by Wende Whitman and Remziye E. Wessel,University of VirginiaMechanistic model captures IgG subclass-specific transfer dynamics. Credit:PLOS Computational Biology(2023). DOI: 10.1371
OB & GYN January 26,2024
Biomedical engineers unveil the dynamics of maternal immune responses

Biomedical engineers unveil the dynamics of maternal immune responses

by Wende Whitman and Remziye E. Wessel,University of VirginiaMechanistic model captures IgG subclass-specific transfer dynamics. Credit:PLOS Computational Biology(2023). DOI: 10.1371
OB & GYN January 26,2024
More News
Week’s Top
Podcasts
... Health spending has been rising across rich countries with different systems ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... At what age do people experience depression for the first time? Depression can affect people over long periods of their lives. Some people experience this condition continuously, while for others, it occu...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com